loadpatents
name:-0.020651817321777
name:-0.009768009185791
name:-0.0067250728607178
Kannan; Sujatha Patent Filings

Kannan; Sujatha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kannan; Sujatha.The latest application filed is for "dendrimer compositions and use in treatment of necrotizing enterocolitis and other gastrointestinal disorders".

Company Profile
5.9.18
  • Kannan; Sujatha - Detroit MI
  • Kannan; Sujatha - Baltimore MD
  • Kannan; Sujatha - Redwood City CA
  • Kannan; Sujatha - Highland MD
  • Kannan; Sujatha - Novi MI US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Injectable dendrimer hydrogel nanoparticles
Grant 11,446,238 - Rangaramanujam , et al. September 20, 2
2022-09-20
Dendrimer Compositions And Use In Treatment Of Necrotizing Enterocolitis And Other Gastrointestinal Disorders
App 20220080056 - Hackam; David ;   et al.
2022-03-17
Compositions And Methods For Treatment Of Peroxisomal Disorders And Leukodystrophies
App 20220071923 - Kannan; Sujatha ;   et al.
2022-03-10
Dendrimer Compositions And Methods For Treatment Of Severe Acute Respiratory Distress Syndrome
App 20210353762 - Cleland; Jeffrey ;   et al.
2021-11-18
Dendrimers For Sustained Release Of Compounds
App 20200390694 - Rangaramanujam; Kannan ;   et al.
2020-12-17
Dendrimer based nanodevices for therapeutic and imaging purposes
Grant 10,561,673 - Rangaramanujam , et al. Feb
2020-02-18
Dendrimers for sustained release of compounds
Grant 10,463,609 - Rangaramanujam , et al. No
2019-11-05
Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes
App 20190247407 - Rangaramanujam; Kannan ;   et al.
2019-08-15
Dendrimer Delivery System And Methods Of Use Thereof
App 20190142964 - Rangaramanujam; Kannan ;   et al.
2019-05-16
Dendrimer based nanodevices for therapeutic and imaging purposes
Grant 10,172,951 - Rangaramanujam , et al. J
2019-01-08
Dendrimer Compositions And Use In Treatment Of Neurological And Cns Disorders
App 20170232120 - RANGARAMANUJAM; Kannan ;   et al.
2017-08-17
Dendrimers For Sustained Release Of Compounds
App 20170216200 - Rangaramanujam; Kannan ;   et al.
2017-08-03
Dendrimer Compositions And Use In Treatment Of Necrotizing Enterocolitis And Other Gastrointestinal Disorders
App 20170119897 - Hackam; David ;   et al.
2017-05-04
Compositions And Methods For Treatment Of Peroxisomal Disorders And Leukodystrophies
App 20170119899 - Kannan; Sujatha ;   et al.
2017-05-04
Injectable Dendrimer Hydrogel Nanoparticles
App 20170028075 - Rangaramanujam; Kannan ;   et al.
2017-02-02
Injectable dendrimer hydrogel nanoparticles
Grant 9,526,794 - Rangaramanujam , et al. December 27, 2
2016-12-27
Dendrimers For Sustained Release Of Compounds
App 20160279054 - Rangaramanujam; Kannan ;   et al.
2016-09-29
Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes
App 20150141350 - Kannan; Rangaramanujam M. ;   et al.
2015-05-21
Dendrimer based nanodevices for therapeutic and imaging purposes
Grant 8,889,101 - Kannan , et al. November 18, 2
2014-11-18
Injectable Dendrimer Hydrogel Nanoparticles
App 20130136697 - Kannan; Rangaramanujam M. ;   et al.
2013-05-30
Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes
App 20120003155 - Kannan; Rangaramanujam M. ;   et al.
2012-01-05
Dendrimers For Sustained Release Of Compounds
App 20110034422 - Kannan; Rangaramanujam ;   et al.
2011-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed